Unknown PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT03014882

Sperm DNA Damage in β-thalassemia Major: Is There a Role for Antioxidants?

Sponsor: Ain Shams University

Conditions DNA Damage Endocrine Disease Fertility Decreased Male

Interventions L-Carnitine and N-acetyl cysteine

Updated 5 times since 2017 Last updated: Jan 6, 2017 Started: Feb 28, 2015 Primary completion: Dec 31, 2017 Completion: Dec 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03014882, this PHASE1/PHASE2 trial focuses on DNA Damage and Endocrine Disease and remains ongoing. Sponsored by Ain Shams University, it has been updated 5 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1/PHASE2

Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1_PHASE2
Feb 2019 — Jan 2021 [monthly]

Unknown Status PHASE1_PHASE2

Status: Active Not Recruiting → Unknown Status
Feb 2017 — Feb 2019 [monthly]

Active Not Recruiting PHASE1_PHASE2

First recorded

Feb 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ain Shams University

Data source: Ain Shams University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt
• Cairo Governorate, Egypt